Hudson Bay Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$96.2M Buy
800,000
+450,000
+129% +$52M 0.33% 62
2025
Q4
$36.8M Sell
350,000
-250,000
-42% -$23.5M 0.12% 154
2025
Q3
$50.4M Sell
600,000
-120,000
-17% -$9.88M 0.17% 98
2025
Q2
$57M Sell
720,000
-389,500
-35% -$31M 0.19% 92
2025
Q1
$99.6M Buy
1,109,500
+569,500
+105% +$53.2M 0.31% 77
2024
Q4
$53.7M Buy
540,000
+40,000
+8% +$4.12M 0.19% 114
2024
Q3
$56.8M Buy
+500,000
New +$59.4M 0.23% 75
2023
Q3
Sell
-1,000,000
Closed -$115M 898
2023
Q2
$115M Buy
+1,000,000
New +$114M 0.84% 35
2019
Q2
Sell
-524,000
Closed -$41.6M 620
2019
Q1
$41.6M Sell
524,000
-524,000
-50% -$39.2M 0.54% 32
2018
Q4
$76.4M Buy
+1,048,000
New +$74M 1.02% 15

Other funds holding MRK

Hudson Bay Capital Management's MRK Position: Q1 2026 in Review

Hudson Bay Capital Management increased its Merck (MRK) stake by 5,539% in Q1 2026, buying an estimated $11.5M and bringing the position to 101,505 shares worth $12.2M. The position accounts for 0.04% of the portfolio, ranked #276.

Hudson Bay Capital Management first reported a position in MRK in Q4 2017 and has held it in 18 quarters since. The position peaked at $115M in Q2 2023. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Hudson Bay Capital Management held 101,505 shares of Merck worth $12.2M as of Q1 2026.
  • Hudson Bay Capital Management bought 99,705 Merck shares in Q1 2026, an estimated $11.5M.
  • Merck made up 0.04% of Hudson Bay Capital Management's portfolio in Q1 2026, its #276 holding.
  • Hudson Bay Capital Management first reported a position in Merck in Q4 2017 and has held it in 18 quarters since.
  • Hudson Bay Capital Management's Merck position peaked at $115M in Q2 2023.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.